PLP2 and colorectal carcinoma: To investigate the effect of LINC00173 on drug resistance in CRC, researchers treated CRC cells with 5-FU after transfection, and the results showed that LINC00173 promoted the 5-FU resistance of CRC cells by binding the miR-765/PLP2 axis [30].